Retatrutide

Retatrutide is an experimental medication for treating type 2 diabetes and obesity. It is an injection administered once weekly, just like Ozempic® and Wegovy®.

Is Retatrutide FDA-Approved for Weight Loss Management?
No, it is not. It is currently in Stage 3 of clinical trials, so your healthcare provider can not yet prescribe it.[2] Although not yet approved, its developer, Eli Lilly, claims it will treat obesity, diabetes, and fatty liver disease by helping patients lose weight, reduce blood sugar levels, and lower fatty acids in their liver.